Notice of Closed Meeting, 29209 [2019-13178]

Download as PDF Federal Register / Vol. 84, No. 120 / Friday, June 21, 2019 / Notices Obtaining Copies of Proposals: Requesters may obtain a copy of the information collection documents from the General Services Administration, Regulatory Secretariat Division (MVCB), 1800 F Street NW, Washington, DC 20405, telephone 202–501–4755. Please cite OMB Control No. 9000– 0074, Contract Funding—Limitation of Costs/Funds, in all correspondence. Dated: June 14, 2019. Janet Fry, Director, Federal Acquisition Policy Division, Office of Governmentwide Acquisition Policy, Office of Acquisition Policy, Office of Governmentwide Policy. [FR Doc. 2019–13138 Filed 6–20–19; 8:45 am] BILLING CODE 6820–EP–P GOVERNMENT ACCOUNTABILITY OFFICE Request for Nominations for the Physician-Focused Payment Model Technical Advisory Committee (PTAC) Government Accountability Office (GAO). ACTION: Request for letters of nomination and resumes. AGENCY: The Medicare Access and CHIP Reauthorization Act of 2015 established the Physician-Focused Payment Model Technical Advisory Committee to provide comments and recommendations to the Secretary of Health and Human Services on physician payment models and gave the Comptroller General responsibility for appointing its members. GAO is now accepting nominations of individuals for this committee. DATES: Letters of nomination and resumes should be submitted no later than July 19, 2019, to ensure adequate opportunity for review and consideration of nominees prior to appointment. Appointments will be made in October 2019. ADDRESSES: Submit letters of nomination and resumes by either of the following methods: Email: PTACcommittee@gao.gov. Include PTAC Nominations in the subject line of the message, or Mail: U.S. GAO, Attn: PTAC Nominations, 441 G Street NW, Washington, DC 20548. FOR FURTHER INFORMATION CONTACT: Greg Giusto at (202) 512–8268 or giustog@ gao.gov if you do not receive an acknowledgement within a week of submission or if you need additional information. For general information, contact GAO’s Office of Public Affairs, (202) 512–4800. jspears on DSK30JT082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:30 Jun 20, 2019 Jkt 247001 29209 Authority: Pub. L. 114–10, Sec. 101(e), 129 Stat. 87, 115 (2015). DEPARTMENT OF HEALTH AND HUMAN SERVICES Gene L. Dodaro, Comptroller General of the United States. Food and Drug Administration [FR Doc. 2019–13249 Filed 6–20–19; 8:45 am] [Docket No. FDA–2019–N–2778] BILLING CODE 1610–02–P Agency Information Collection Activities; Proposed Collection; Comment Request; Threshold of Regulation for Substances Used in Food-Contact Articles DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— RFA–TS–19–002, Multi-Site Study of the Health Implications of Exposure to PFAS-Contaminated Drinking Water. Date: July 24–25, 2019. Time: 8:30 a.m.–5:00 p.m., EDT. Place: W Atlanta-Buckhead, 3377 Peachtree Rd, NE, Atlanta, GA 30326. Agenda: To review and evaluate grant applications. For Further Information Contact: Mikel Walters, Ph.D., Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, Mailstop F–63, Atlanta, Georgia 30341, Telephone (404) 639– 0913, MWalters@cdc.gov. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2019–13178 Filed 6–20–19; 8:45 am] PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 Food and Drug Administration, HHS. ACTION: Notice of Closed Meeting BILLING CODE 4163–18–P AGENCY: Notice. The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on requests for data needed to evaluate requests for threshold of regulation exemptions for substances used in food-contact articles. DATES: Submit either electronic or written comments on the collection of information by August 20, 2019. ADDRESSES: You may submit comments as follows. Please note that late, untimely filed comments will not be considered. Electronic comments must be submitted on or before August 20, 2019. The https://www.regulations.gov electronic filing system will accept comments until 11:59 p.m. Eastern Time at the end of August 20, 2019. Comments received by mail/hand delivery/courier (for written/paper submissions) will be considered timely if they are postmarked or the delivery service acceptance receipt is on or before that date. SUMMARY: Electronic Submissions Submit electronic comments in the following way: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https:// www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or E:\FR\FM\21JNN1.SGM 21JNN1

Agencies

[Federal Register Volume 84, Number 120 (Friday, June 21, 2019)]
[Notices]
[Page 29209]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-13178]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Chief Operating 
Officer, CDC, pursuant to Public Law 92-463. The grant applications and 
the discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--RFA-TS-19-002, Multi-Site Study 
of the Health Implications of Exposure to PFAS-Contaminated Drinking 
Water.
    Date: July 24-25, 2019.
    Time: 8:30 a.m.-5:00 p.m., EDT.
    Place: W Atlanta-Buckhead, 3377 Peachtree Rd, NE, Atlanta, GA 
30326.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Mikel Walters, Ph.D., Scientific 
Review Official, NCIPC, CDC, 4770 Buford Highway NE, Mailstop F-63, 
Atlanta, Georgia 30341, Telephone (404) 639-0913, [email protected].
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-13178 Filed 6-20-19; 8:45 am]
 BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.